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Abstract
Human infections with subtype H7 avian influenza viruses have been reported as early as 1979. In 1996, a genetically stable
24-nucleotide deletion emerged in North American H7 influenza virus hemagglutinins, resulting in an eight amino acid
deletion in the receptor-binding site. The continuous circulation of these viruses in live bird markets, as well as its
documented ability to infect humans, raises the question of how these viruses achieve structural stability and functionality.
Here we report a detailed molecular analysis of the receptor binding site of the North American lineage subtype H7N2 virus
A/New York/107/2003 (NY107), including complexes with an avian receptor analog (39-sialyl-N-acetyllactosamine, 39SLN)
and two human receptor analogs (69-sialyl-N-acetyllactosamine, 69SLN; sialyllacto-N-tetraose b, LSTb). Structural results
suggest a novel mechanism by which residues Arg220 and Arg229 (H3 numbering) are used to compensate for the deletion
of the 220-loop and form interactions with the receptor analogs. Glycan microarray results reveal that NY107 maintains an
avian-type (a2-3) receptor binding profile, with only moderate binding to human-type (a2-6) receptor. Thus despite its
dramatically altered receptor binding site, this HA maintains functionality and confirms a need for continued influenza virus
surveillance of avian and other animal reservoirs to define their zoonotic potential.
Citation: Yang H, Chen L-M, Carney PJ, Donis RO, Stevens J (2010) Structures of Receptor Complexes of a North American H7N2 Influenza Hemagglutinin with a
Loop Deletion in the Receptor Binding Site. PLoS Pathog 6(9): e1001081. doi:10.1371/journal.ppat.1001081
Editor: Fe ´lix A. Rey, Institut Pasteur, France
Received March 16, 2010; Accepted July 28, 2010; Published September 2, 2010
This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration which stipulates that, once placed in the public
domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose.
Funding: This work was funded by the Centers for Disease Control and Prevention. Use of the Advanced Photon Source at Argonne National Laboratory was
supported by the U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357. Glycan microarrays as
well as glycans for direct binding experiments were produced for the Centers for Disease Control by the CFG funded by National Institute of General Medical
Sciences Grant GM62116. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: fwb4@cdc.gov
Introduction
Influenza is an acute respiratory virus that infects up to 20% of
the population in the United States, resulting in ,36,000 deaths
annually [1,2]. The two membrane glycoproteins on the surface of
influenza A virus, hemagglutinin (HA), which functions as the
receptor binding and membrane fusion glycoprotein in cell entry,
and neuraminidase (NA), which functions as the receptor destroying
enzyme in virus release, form the basis for defining subtypes [3]. To
date, 16 HA (H1–H16) and 9 NA (N1–N9) have been identified in
avian species [4], while in the last century, only three subtypes,
H1N1 in1918and2009,H2N2 in1957,and H3N2 in1968[5,6,7],
have successfully adapted to humans. Hemagglutinin binds to sialic
acid (SA) glycans present on host cell surfaces. The receptors on
epithelial cells of the human upper respiratory tract are mainly
a2-6-linked SA moieties [8]. Since avian influenza viruses pre-
dominately bind a2-3-linked SA, and human influenza viruses
preferentially bind to a2-6-linked SA, human infection by avian
influenzaviruses is rare [9].However, since1997 a growingnumber
ofhumancasesofavianinfluenzainfectionhavebeenreported [10],
including H5N1, H7N2, H7N3, H7N7, and H9N2 strains [11].
Although the current situation with the pandemic H1N1 influenza
virus dominates public health efforts, the prospect of a novel
pandemic emerging from these isolated cases continues to be a
major public health threat around the world.
Early cases of human infection by H7 influenza viruses are reported
as far back as 1979 [12,13]. Since 2002, multiple outbreaks and
human infections of H7 subtype viruses; within both Eurasian and
North American lineages have been reported. In the Netherlands in
2003, a highly pathogenic avian influenza (HPAI) H7N7 outbreak
resulted in more than 80 cases of human infections, including one
fatality [14,15]. In New York in 2003, a single case of human
respiratory infection of H7N2 was reported [16] and in British
Columbia in 2004, an H7N3 virus caused two cases of conjunctivitis
[17,18]. More recently in 2007, the United Kingdom reported several
cases of low pathogenic avian influenza (LPAI) H7N2 virus infections
that caused influenza-like illness and conjunctivitis [19].
Since 1996, H7 viruses of the North American lineage have
been circulating in regional live bird markets [20], containing a
24-nucleotide deletion resulting in an eight amino acid deletion in
the receptor-binding site (RBS) of HA (Figure S1). The recent
human infections with H7 in North America have raised public
health concerns as to how these viruses adapt to such a dramatic
structural change while remaining one of the predominant
circulating viral strains. A recent study of H7 viruses isolated
from previous outbreaks revealed efficient replication in both
mouse and ferret animal models [21]. In particular, ferret studies
with A/New York/107/2003 (NY107), an H7N2 virus isolated
from a man in New York, not only showed efficient replication in
the upper respiratory tract of the ferret but also the capacity for
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both an increased preference for a2-6 and decreased preference for
a2-3-linked sialosides of this virus compared to the other avian
influenza viruses was shown by previous glycan microarray analysis
but less so by a competitive solid-phase binding assay [22,23].
Here we report a detailed molecular analysis of the RBS of the
HA from North American lineage H7N2 virus, NY107, including
glycan microarray analyses and structural analyses of the HA in
complex with an avian receptor analog (39-Sialyl-N-acetyllactosa-
mine, 39SLN) and two human receptor analogs (69-Sialyl-N-
acetyllactosamine, 69SLN; Sialyllacto-N-tetraose b, LSTb). These
results provide important insight into the interaction of H7 HAs
with both avian and human hosts.
Results
Overall structure
By using x-ray crystallography, the structure of H7 HA from the
NY107 virus was determined to 2.6 A ˚ resolution (Table 1). In
addition, we also report three H7 HA receptor complex structures,
with avian receptor analog (39SLN) to 2.7 A ˚ resolution and with
human receptor analogs (69SLN and LSTb) to 3.0 A ˚ and 2.6 A ˚
resolution, respectively (Table 1). The overall structure of NY107
is similar to other reported HA structures with a globular head
containing the RBS and vestigial esterase domain, and a
membrane proximal domain with its distinctive, central helical
stalk and HA1/HA2 cleavage site (Figure 1A). Although five
asparagine-linked glycosylation sites are predicted in the NY107
HA monomer, interpretable electron density was observed at only
two sites, Asn38 in HA1 and Asn82 in HA2 (all residue numbers
are based on H3 numbering). At these sites, only one or two N-
acetyl glucosamines could be interpreted.
During viral replication, HA is synthesized as a single chain
precursor (HA0) and cleaved by specific host proteases into the
infectious HA1/HA2 form. In baculovirus expression systems,
highly pathogenic HAs, with a polybasic cleavage site, are
expressed as an HA1/HA2 form [24], whereas HAs with
monobasic cleavage sites (single Arg) from low pathogenic viruses
are expressed as the HA0 form [25]. NY107 is regarded as a low
pathogenic virus, and as expected, was produced in the HA0
form (Figure S2). However, subsequent digestion with thrombin
protease to remove the His-tag resulted in cleavage to a profile on
SDS-PAGE comparable to that of an HA1/HA2 form (Figure S2).
A comparison of the NY107 cleavage site with the consensus
cleavage pattern in the MEROPS database (http://merops.
sanger.ac.uk) suggests it to be a possible thrombin cleavage site.
Based on their molecular phylogenies, HAs are divided into two
groups and five clades: group 1 includes H8, H9, and H12; H1,
H2, H5, and H6; H11, H13 and H16; group 2 includes H3, H4,
and H14; H7, H10 and H15 [26]. Among all available HA
structures, we selected ten representative HAs from both avian and
human subtypes for structural analysis. As expected, NY107 HA is
structurally very similar to the Avian-H7 in all comparisons and
closely related to H3, the other group 2 members used in the
analyses (Tables S1 and S2).
The receptor binding site
The RBS is at the membrane distal end of each HA monomer
and its specificity for sialic acid and the nature of its linkage to a
vicinal galactose residue is a major determinant of host range-
restriction. The consensus RBS for all current HAs is composed of
three major structural elements: a 190-helix (residues 188–194), a
220-loop (residues 221–228), and a 130-loop (residues 134–138).
In addition, highly conserved residues (Tyr98, Trp153, His183,
and Tyr195) form the base of the pocket.
Although the NY107 RBS is similar to other subtypes (H1, H2,
H3, H5, and H9), a previously observed specific feature of H7 HAs,
is also observed in the NY107 150-loop region: two residues inserted
at position 158 result in this loop protruding more than 6A ˚ towards
the binding site compared to other subtype HAs (Figure 1B and
Table S2) [27]. More interestingly, the eight amino acid deletion,
only found in the North American lineage H7s, from position 221 to
228 (Figure S1), resulted in a complete loss of the 220-loop
(Figure 1B). Sequence alignment shows that Arg220 and Arg229 are
conserved in all influenza A HA subtypes (Figure S1), but structural
alignment of NY107 HA shows Arg220 occupying the Gly228
position, and the much shorter loop turns at residue Pro217
(Figure 1C). The Ca distance between NY107 Arg220 and its
homolog in the Av-H7 structure (PDB: 1TI8) [27] is 5.8A ˚,a n dt h e y
point in opposite directions (Figure 1C). The side chain direction of
Av-H7 Arg220 is almost parallel with the beta sheet after Arg229,
whereas the NY107 Arg220 points downward to the binding pocket.
The Ca position of Arg229 in both H7 structures remains the same,
except the side chain in the NY107 swings away by about 5.9A ˚
(Figure 1C) and could help to stabilize this region by forming a
hydrogen bond to the mainchain carbonyl of Gln210 in the
neighboring monomer. In the absence of the 220-loop in NY107
HA,uponglycan binding the longsidechainofArg220compensates
for its loss and is displaced 4A ˚ upward to form hydrogen bonds with
receptor analogs inside the binding pocket (Figure 1D).
Effect of loop truncation on the receptor binding
specificity of NY107
Previously, mutations in the HA receptor binding domains of
H1N1 (Glu190Asp/Gly225Asp) and H2N2/H3N2 (Gln226Leu
and Gly228Ser) subtypes were responsible for adaptation of these
viruses to pandemic strains [24,28,29,30]. Due to missing residues
221–228 in the NY107 HA RBS, neither mechanism for
adaptation is possible. Thus, in order to look more closely at the
role of the missing loop and its effect on receptor specificity, we
first subjected the recombinant HA (recHA) to glycan microarray
analyses and compared it to a reverse genetics-derived NY107
virus, and a co-circulating Eurasian virus and recHA, A/
Author Summary
Influenza virus adaptation to different hosts usually results
in a switch in receptor specificity of the viral surface coat
protein, hemagglutinin. Indeed, the hemagglutinin sub-
types from the last two human influenza pandemics of the
20
th Century (H2 in 1957 and H3 1968) both adapted
successfully to human-type receptor specificity through
only two amino acid mutations in the receptor binding
pocket (Glutamine226RLeucine and Glycine228RSerine).
The recent human infections reported with other avian
subtypes such as H5, H7 and H9 have raised public health
concerns and focused efforts on identifying potential
subtypes from which a future pandemic strain may
emerge. Since 1996, H7 viruses of the North American
lineage have been circulating in regional live bird markets,
containing an eight amino acid deletion in the receptor-
binding site of HA. Here we report a detailed structural
analysis of the receptor binding site of a hemagglutinin
from the North American lineage of H7N2 viruses, in
complex with avian and human receptor analogs, to
understand how these viruses have adapted to such a
dramatic structural change in the binding site while
remaining one of the predominant circulating viral strains.
Structure of a North American H7 Hemagglutinin
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sequence in the 220-loop and it also infected a human [15].
Glycan microarray analysis of recombinant NY107 (Figure 2A
and Table 2) revealed a highly restricted binding profile with
strong binding to only a2-3 sulfated (#4–8), a2-3 branched (#9–
11) and mixed a2-3/a2-6 branched sialosides (#60–64) as well as
to the long linear sialyl di- and tri-lactosamines (#22, 24). Weak
binding was also observed (above background) to other a2-3
glycans on the array. The recombinant NY107 also revealed a
strict glycan binding preference to only one a2-6 glycan, the
internal structure, Galb1-3(Neu5Aca2-6)GlcNAcb1-3Galb1-4Glc
(#58; LSTb) (Figure 2A), a glycan highlighted in a previous study
[22]. The virus with higher valency and avidity revealed stronger
binding to all a2-3 groups, in addition to the branched di-sialyl a2-
6 biantennary structures (#46–48) as well the LSTb (#58)
(Figure 2B and Table 2). In contrast, the NL219 recHA (Figure 2C
and Table 2) bound well to only the avian a2-3 containing sialyl-
glycans (sulfated, branched, linear and fucosylated). Its corre-
sponding virus also reflected this specificity although it also
revealed strong binding to a2-3 N-glycolylneuraminic acid
(Neu5Gc) containing glycans (#66–70) (Figure 2D and Table 2).
To further assess the effect of the missing 220 loop on HA
structural stability and receptor specificity it was essential to
evaluate these functions on the ancestral HA containing the full
length 220-loop. To this end, we engineered an HA with an avian
H7 consensus (PQVNGQSG) 220-loop re-introduced (NY107-
220ins) into the NY107 HA and recovered this virus by reverse
genetics. Compared to the NY107 virus (Figure 2A) glycan
microarray analyses of the resulting NY107-220ins virus (Figure 3A
and Table 2) revealed a decrease in binding to branched (#9–11)
and linear (#12–27) a2-3 sialosides and a loss of binding to the
branched di-sialyl a2-6 biantennary structures (#46–48), LSTb
(#58) as well as the mixed a2-3/a2-6 branched sialosides (#60–
64). In addition, sequence analysis of the NY107-220ins HA
revealed the presence of quasispecies in the second position of the
inserted loop, P(Q/K)VNGQSG, suggesting that re-introduction
of the loop alone is not tolerated and does not create an avian-type
binding profile. Thus other amino acid substitutions in the HA
might have co-evolved with the deletion of the 220 loop to help
stabilize the RBS/HA to maintain functionality.
When viruses containing this 220-loop deletion emerged in North
America in the mid 90’s, four additional amino acid substitutions,
Gly114Arg, Asp119Gly, Gly186Glu and Gly205Arg, in the HA1 as
well as an Asp19Asn in the HA2 chain were also introduced to most
of the circulating isolates. Of these, Gly186Glu and Gly205Arg in
the HA1 are close to the RBS, at the monomer interface, and could
potentially modulate its structure and/or function. NY107 viruses
witha restored consensus220-loop anda singleGlu186Gly(NY107-
ins-186) or Arg205Gly (NY107-ins-205) substitution as well as the
Glu186Gly/Arg205Gly double substitution (NY107-ins-186/205)
were derived by reverse genetics and evaluated. Glycan microarray
analysis for the three resulting viruses revealed similar glycan
binding profiles with increased binding to a2-3 sialosides, including
mixed a2-3/a2-6 branched sialosides (#60–64), a2-3 Neu5Gc
(#66–70), but limited binding to the a2,6 sialosides (Figures 3B, 3C,
3D), resulting in a binding profile virtually identical to that of the
NL219 virus and other avian influenza viruses (Figure 2D) [30].
Sequence analysis of the three reverse genetics derived viruses
revealed no mutations/quasispecies inthe HAsof eitherthe NY107-
ins-186 or the NY107-ins-186/205 virus stocks, indicative of
replication fitness. For the NY107-ins-205 virus however, a
Glu186Gly substitution emerged in the HA after only two passages
in eggs following recovery from DNA transfection, indicating the
importance of the co-variant position 186 with respect to HA
functionality/glycan specificity. Altogether, the data indicates that
the H7 subtype avian influenza viruses that were circulating in
Table 1. Data collection and refinement statistics.
NY107 NY107+39SLN NY107+69SLN NY107+LSTb
Data collection
Space group P212121 P212121 P212121 P212121
Cell dimensions (A ˚) 66.96, 115.92, 251.61 67.80, 116.70, 249.84 66.60, 116.58, 250.68 67.08, 116.52, 251.95
Resolution (A ˚) 50-2.6 (2.69-2.60)
a 30-2.7 (2.80-2.70) 50-3.0 (3.11-3.0) 50-2.6 (2.69-2.60)
Rsym or Rmerge 10.6 (41.3) 14.6 (48.6) 14.3 (35.4) 12.2 (31.5)
I/s 39.6 (2.0) 24.3 (1.7) 34.2 (8.2) 40.5 (9.9)
Completeness (%) 99.2 (99.0) 99.3 (94.6) 92.3 (75.6) 91.3 (86.2)
Redundancy 7.2 (6.2) 5.8 (5.5) 4.9 (4.4) 10.9 (11.2)
Refinement
Resolution (A ˚) 50-2.6 (2.67-2.60) 30-2.7 (2.77-2.70) 50-3.0 (3.08-3.00) 50-2.6 (2.67-2.60)
No. of reflections (total) 57285 51770 33421 53603
No. of reflections (test) 3053 2769 1779 2842
Rwork/Rfree 21.7/25.6 21.4/26.4 20.5/26.0 20.4/24.7
No. of atoms 11795 11878 11648 12108
r.m.s.d.- bond length (A ˚) 0.006 0.006 0.008 0.006
r.m.s.d.- bond angle (u) 0.905 0.974 1.085 0.859
MolProbity
b scores
Favored (%) 96.9 96.5 94.3 97.1
Outliers (%) (No. of residues) 0.1 (1/1434) 0.0 (0/1429) 0.1 (2/1433) 0.1 (2/1435)
aNumbers in parentheses refer to the highest resolution shell.
bReference [51].
doi:10.1371/journal.ppat.1001081.t001
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classic avian a2-3 sialoside binding preference. In order for the 220-
loop deletiontobe tolerated, concurrentGly186Gluand Gly205Arg
substitutions in the vicinity of RBS of HA emerged to achieve a
restricted a2-3 binding profile and only a moderate/limited increase
in binding to branched di-sialyl a2-6 biantennary structures (#46–
48) as well the a2,6 internal sialoside, LSTb (#58).
NY107 avian receptor complex
To understand from a structural perspective how NY107
interacts with host receptors, we solved the structure of NY107
in complex with an avian and two human receptor analogs.
For the avian receptor analog, 39SLN, the electron density
maps revealed well-ordered features for the Sia-1, Gal-2, and
GlcNAc-3 in the NY107 HA complex structure (Figure 4A).
Structural comparison of NY107 HA binding to other, H1, H2,
H3, H5, and H9 subtypes (Figure S2A) revealed that 39SLN
binding to NY107 resembled binding of the other published
HAs. Indeed, the terminal Sia-1 moiety is positioned almost
identically in all structures, and forms the majority of hydrogen
bonds and contacts with residues in the RBS (Figure 4A and
Table S3).
Figure 1. NY107 HA monomer and comparison of its RBS to other HA structures. (A) One monomer is shown with the HA1 chain colored in
green and the HA2 chain in cyan. The location of the receptor binding site and the HA1/HA2 cleavage site are circled. (B) The superposition of
receptor binding domains of NY107 (green), Av-H7 (marine), 1918-Hu-H1 (magenta), Hu-H5 (yellow), Hu-H3 (orange), and Sw-H9 (grey). The proximity
of Arg220 and Gln226 are highlighted. Three structural elements comprising this binding site are labeled. The two major differences are the extended
150-loop and the deletion of 220-loop of NY107. (C) Overlap of NY107 (green) and Av-H7 (marine) (PDB: 1TI8) illustrates the compensatory effect of
R220 bringing it close to the position occupied by G228 in the avian HA. (D) Overlap of the NY107 (green), NY107- 39SLN (orange), NY107-69SLN (red),
and NY107-LSTb (magenta) structures. All the figures were generated and rendered with the use of MacPyMOL [56].
doi:10.1371/journal.ppat.1001081.g001
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very close interactions with Gal-2 of 39SLN via residue Gln226
which is important in receptor specificity and host adaptation. For
example, in the avian H7/39SLN HA structure it interacts with
Gal-2 O4 [31]. In the NY107 HA structure, although Gln226 is
absent and no other residue occupies the same space as Gln226
(Figure 1B), Arg220 does forms a hydrogen bond between Arg220
NH2 and Gal-2 O4 (Figure 4A). Interestingly, although there was
interpretable density for the GlcNAc-3 (Figure 4A and Figure
S4B), no hydrogen bonding was apparent between the HA and the
GlcNAc-3, which is consistent with other reported structures [32].
Thus, for binding to avian receptors, the trans conformation of
a2-3 linkages is essential and perhaps only the first two saccharides
are required. Indeed, due to the absence of 220-loop in the NY107
HA structure, the ‘‘aperture’’ of the RBS formed by 220-loop and
130-loop in regular HAs is increased by ,10 A ˚, so that the
branched, internal, and perhaps more complicated glycans might
be accommodated more efficiently.
NY107 human receptor complexes
In the NY107/69SLN complex, only Sia-1 and Gal-2 are
ordered (Figure 4B). The Sia-1 remains in the same position as
previously analyzed glycan/HA complexes from H1, H2, H3, H5,
and H9 (Figure S3B), whereas the Av-H7 complex structure with
Sialyllacto-N-tetraose c (LSTc) did not reveal any density for the
Sia-1 in the receptor binding site [31]. The Gal-2 position varies
significantly among different subtypes. Compared to the human-
adapted H1 HA [32], Gal-2 in the NY107 HA is 3A ˚ higher, and
thus is further from the protein (Figure S3B). In NY107, the Gal-2
only forms an intramolecular, saccharide-saccharide interaction
with Sia-1. The poor electron density map and fewer interactions
with protein residues suggest that the cis conformation of a2-6
Figure 2. Receptor specificity of NY107 recHA and virus. Glycan microarray analysis of recombinant NY107 HA (A) and NY107 virus (B)
compared to the recHA (C) and virus (D) from a Eurasian lineage A/Netherlands/219/2003 H7 influenza virus that was circulating in the same year and
also infected a human. Colored bars highlight glycans that contain a2-3 SA (blue) and a2-6 SA (red), a2-6/a2-3 mixed SA (purple), N-glycolyl SA
(green), a2-8 SA (brown), b2-6 and 9-O-acetyl SA, and non-SA (grey). Error bars reflect the standard error in the signal for six independent replicates
on the array. Structures of each of the numbered glycans are found in Table S4.
doi:10.1371/journal.ppat.1001081.g002
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with NY107.
Glycan array results with NY107 revealed a strong binding
signal for the internal a2-6 sialoside, LSTb. To further investigate
this interaction, we solved the structure of the NY107/LSTb
complex. The final model contained Sia-1, NAG-2, Gal-3, and
Gal-5 in the RBS. Although glycan microarray data indicated
NY107 to have a specific affinity for LSTb, few interactions were
apparent from the crystal structure. Sia-1 still forms multiple
hydrogen bonds with residues in the RBS (Table S3 & Figure 4C).
The branched Gal-5 interacts with Ser137, to help stabilize the
LSTb binding. However, Arg220 and Lys193, the two residues
showing close binding with 39SLN, did not form any hydrogen
bonds with LSTb. In the structure, Gal-5 also interacts with a
crystal packing symmetry mate and thus the flexibility of whole
LSTb may be restricted. In solution, with more freedom, the
LSTb should be able to tilt closer to the RBS, and thus Glc-4 may
have more interactions with the 190-helix than seen in the crystal
structure.
Discussion
Human infections by avian influenza viruses, including H7
subtypes, continue to pose a major public health threat. Although
the species barrier prevents avian influenza viruses from
widespread infection of the human population, the molecular
determinants of efficient interspecies transmission and pathoge-
nicity are still poorly understood. The viral coat protein HA
however, is perhaps a critical molecule since previous pandemic
viruses modified their receptor specificity and overcame the
interspecies barrier to spread in the human population. Although
HA structures alone and in complex with receptor analogs provide
considerable insight into receptor binding, it is clear that HAs from
different species and subtypes have significant structural variation.
Indeed, low-pathogenic H7N2 avian influenza viruses with an 8
amino acid deletion within its RBS started to circulate in live-bird
markets in the northeast United States in 1996. Despite what one
would consider a debilitating mutation, these viruses have been
reported as the predominant isolate [33]. Whether such a deletion
contributed to their evolutionary success and how are an
important questions, especially in light of NY107’s ability to
produce respiratory illness in humans [16], as well as its reported
increased affinity for human-type receptors and ability for contact
transmission in ferrets [21]. To try to help answer these questions,
we have analyzed the molecular structures of NY107 and its
complexes with receptor analogs to explain receptor specificity at
the molecular level.
The crystal structures of NY107 and its complexes with both
avian and human receptor analogs describe a mechanism as to
how an influenza virus might adapt by dramatically altering its
RBS, and still be functional. Arg220 of the HA1 chain of NY107
compensates for the loss of the 220-loop, by forming hydrogen
bonds with Gal-2 from the avian analog (binding was not observed
in either of the structures complexes with the human analogs).
However, in the LSTb complex, branched Gal-5 forms extra
interactions with the 130-loop, thus improving the binding
preference for this particular glycan. Consistent with the structural
evidence, glycan microarray analyses of NY107 revealed a strong
binding preference for the branched a2-6 sialoside, LSTb. Except
for the absence of the 220-loop, other key residues within the RBS
are conserved in NY107 and thus, direct interactions with sialic
acid are maintained.
The 220-loop is recognized as one of the three crucial structural
elements in the RBS. Aside from the North American lineage
H7N2 viruses, which have been circulating with a deletion (221–
228) in this loop, there has been one other report describing a
seven amino acid deletion (224–230) in a laboratory generated
H3N2 escape mutant which was reported to have a slightly
Table 2. Comparison of the sialoside receptor specificity of the HAs from H7 influenza viruses.
Glycan Group
Graph
Number
a
NY107
RecHA
NY107
Virus
NY107-ins
Virus
NY107-ins
E186G Virus
NY107-ins
R205G Virus
NY107-ins E186G/
R205G Virus
NL219
RecHA
NL219
Virus
a2-3
Sulfated 4–8 +++
b +++ +++ +++ +++ +++ +++ +++
Branched 9–11 +++ +++ + +++ +++ +++ +++ +++
Linear 12–27 + +++ + +++ +++ +++ +++ +++
Fucosylated 28–34 2 +++ +++ +++ +++ +++ +++ +++
a2-6
Sulfated 41 22 2 2 2 2 2 2
Branched mono-sialyl 42–45, 49 22 2 2 2 2 2 2
Branched di-sialyl 46–48 2 +++ 22 2 2 2 2
Linear 50–56 22 2 2 2 2 2 2
Internal 58–59 +++ +++ 22 2 2 2 2
Other
Sialic acid 1–2 2 +++ + 222 2 2
a2-3/a2-6 Branched 60–64 22 2 +++ +++ +++ +++ +++
Neu5Gc
c 65–72 22 2 +++ +++ +++ 2 +++
aMembers of each group are identified according to the graph number used in the microarray data in Figures 2 and 3 and correspond to numbers in the complete
glycan list (Table S4).
bBinding of samples to glycan subclasses are qualitatively estimated based on relative strength of the signal for the data shown in Figures 2 and 3: strong (+++), weak
(+), absent (2).
cN-glycolylneuraminic acid.
doi:10.1371/journal.ppat.1001081.t002
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assay [34]. Meanwhile, the equivalent region in the hemaggluti-
nin-esterase-fusion (HEF) protein of influenza C virus reveals a
rearrangement resulting in a truncated 260-loop in its RBS (Figure
S5) [35]. However, without structural data with appropriate
receptor analogs, it is not possible to compare the role of these loop
variants in receptor binding to the H7 HA structure described
here.
When compared to NL219, another co-circulating H7 avian
virus HA (Figure 2C and D), overall binding to a2-3-linked
glycans was markedly reduced, while increased binding to a2-6-
linked receptors was only marginal. However, these results focus
attention on only 2 sub-classes of human-type receptors that may
be important for infection (and transmission in ferrets). The
NY107 virus interaction with biantennary glycans (Figure 2B),
although weak (not seen in Figure 2A with recHA), is a possible
route for virus entry as biantennary structures are common on
tissues, i.e. glycan profiling data from human lung tissue on the
Consortium for Functional Glycomics (CFG) web site. In addition,
the internal sialoside, LSTb, was observed in both virus and
recHA microarray data, suggesting this type of glycan has good
affinity for this HA. The significance of this is unknown since
LSTb has only been described in human milk [36].
Interestingly, NY107 and NL219 virus receptor binding and
specificity has been addressed previously using glycan microarray
analysis that reported a significantly increased preference for a2-6
and decreased preference for a2-3-linked sialosides [22]. In
addition, the same viruses were also included in a recent study
from Gambaryan et al. using a competitive solid-phase binding
assay [23]. Our findings confirm and extend the receptor binding
specificity reported by these authors in that they reported both
viruses binding to sulfated sialylglycans with a lactosamine (Galb1-
4GlcNAc core and reported only a moderate binding affinity for
a2-6-sialyllactosamine, the human-type receptor analog used in
their assay.
The 220-loop is an integral feature of the receptor binding site,
and thus one would predict that such a deletion might have
compromised this strain to be deleted from the population of
circulating viruses. However, this was not the case [33] and its
existence appears to be in part due to the additional mutations at
Figure 3. Effect of 220-loop deletion and additional RBS mutations on NY107 receptor specificity. NY107 was engineered to restore the
220-loop to a consensus full-length HA from 1996 (A) and additional co-variant amino acid substitutions, Glu186Gly (B), Arg205Gly (C) and the double
mutant Glu186Gly/Arg205Gly (D) to restore, on the NY107 framework, an HA RBS found in viruses prior to the introduction of the deletion in North
American viruses. Colored bars group glycans as described in Figure 3. Error bars reflect the standard error in the signal for six independent replicates
on the array. Structures of each of the numbered glycans are found in Table S4.
doi:10.1371/journal.ppat.1001081.g003
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residues mutated back to the pre-1994 consensus sequence
resulted in a classic avian influenza virus binding profile. The
emergence of the Glu186Gly mutation in the HA of the NY107-
ins-205 mutant after only two passages of the rescued virus in
eggs, also indicates the importance of these positions for HA
functionality/glycan specificity. Analysis of the structural data
reveals that positions 186 and 205 are on opposite sides of a
monomer but are both close to the 220-loop deletion region in
the trimeric form. The Glu at position 186 is close to Arg220 and
may interact with Arg220 when binding avian receptors. Position
205 in the neighboring monomer may be important in trimer
stability and maintaining RBS functionality. If one models the pre-
1996 220-loop restored into the NY107 structure, Arg205, Glu186
and the loop all clash, thus explaining the Glu186Gly mutation
that emerged in the NY107-ins-205 virus HA after limited egg
passage.
The NY107 RBS with its more restricted a2-3 glycan binding
preference and weak/moderate increase in a2-6 binding may have
given the virus a selective advantage to be maintained in poultry at
live bird markets and supplying farms. Certain terrestrial birds,
such as quails and chickens, have recently been shown to present
both human and avian types of receptors in the trachea and
intestine [37,38,39]. Although it is not known what specific glycans
are presented in these animals, it is conceivable that a virus with
mixed specificity might have a distinct advantage over avian
viruses that have specific avian receptor requirements, particularly
in bird markets where multiple species coalesce. Previous results
with H7N2, H9N2 and H5N1 viruses all highlight the fact that an
increase in a2-6-binding preference is not sufficient for efficient
transmission of avian influenza viruses to humans [22,40,41].
Although it remains to be seen whether prolonged circulation of
viruses in terrestrial birds, such as domestic chickens, can provide a
possible route for viruses to adapt for efficient human infection
[11], continued surveillance of influenza viruses from avian and
other animal reservoirs is urgently needed to define their zoonotic
potential.
Materials and Methods
Cloning
Based on H3 numbering [42], cDNA corresponding to residues
11–329 (HA1) and 1–176 (HA2) of the ectodomain of the
hemagglutinin (HA) from A/New York/107/2003 (H7N2;
Genbank:ACC55270) and A/Netherlands/219/2003 (H7N7;
Genebank: AAR02640) was cloned into the baculovirus transfer
vector, pAcGP67-A (BD Biosciences), incorporating a C-terminal
thrombin cleavage site, a ‘‘foldon’’ sequence [43] and a His-tag at
the extreme C-terminus of the construct to enable protein
purification [25,44]. Transfection and virus amplification were
carried out according to the baculovirus expression system manual
(BD Biosciences Pharmingen).
Figure 4. Glycan interactions within the NY107 RBS. The top panel shows the interactions of NY107 with (A) 39SLN, (B) 69SLN and (C) LSTb.
NY107 is shown in orange/red/magenta cartoon respectively. The interacting HA residues are shown as green sticks. The bottom panel shows the
electron density map of the ligands. The NY107 is shown in the same colors as above, and the ligands are shown as green sticks, the 2fo-fc electron
density maps (contoured at 1s) are shown in grey. Simulated annealing omit maps are shown in supplementary Figure S4.
doi:10.1371/journal.ppat.1001081.g004
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Soluble NY107 was recovered from the cell supernatant by metal
affinity chromatography using Ni-NTA resin (Qiagen Inc.). Frac-
tions containing NY107 were pooled and dialyzed against 10 mM
Tris-HCl, 50 mM NaCl, pH 8.0, then subjected to ion-exchange
chromatography (IEX) using a Mono-Q HR 10/10 column (GE
Healthcare). IEX purified NY107 was subjected to thrombin digest
(3 units/mg protein; overnight at 4uC) and purified by gel filtra-
tion chromatography using a Superdex-200 16/60 column (GE
Healthcare) and 50 mM Tris-HCl, 100 mM NaCl, pH 8.0 as
running buffer. Protein eluting as a trimer was buffer exchanged
into 10 mM Tris-HCl, 50 mM NaCl, pH 8.0 and concentrated to
14.5 mg/ml for crystallization trials. At this stage, the protein
sample still contained the additional plasmid-encoded residues at
both the N (ADPG) and C terminus (SGRLVPR).
Crystallization, ligand soaking and data collection
Initial crystallization trials were set up using a Topaz Free
Interface Diffusion (FID) Crystallizer system (Fluidigm Corpora-
tion, San Francisco, CA). Crystals were observed in several
conditions containing PEG 3350 or PEG 4000. Following opti-
mization, diffraction quality crystals for NY107 were obtained at
room temperature using a modified method for microbath under
oil [45], by mixing the protein with reservoir solution containing
20% PEG 3350, 0.2 M magnesium chloride at pH 7.2. For
receptor analog complexes, crystals were soaked for 3 hours in the
crystallization buffer containing 10 mM 39SLN or 69SLN (V-labs
Inc., Covington, LA), or overnight in 10mM LSTb (Sigma, St.
Louis, MO). All crystals were flash-cooled at 100K using 20%
glycerol as the cryo-protectant. Datasets were collected at
Advanced Photon Source (APS) beamlines 22 ID and BM at
100K. Data were processed with the DENZO-SACLEPACK suite
[46]. Statistics for data collection are presented in Table 1.
Structure determination and refinement
The structure of NY107 was determined by molecular
replacement with Phaser [47] using the structure of the avian
H7 (Av-H7) from A/turkey/Italy/2002, pdb:1TI8 (HA1, 78%
identity; HA2, 90% identity) as the searching model. One HA
trimer occupies the asymmetric unit with an estimated solvent
content of 58% based on a Matthews’ coefficient (Vm) of 2.9 A ˚ 3/
Da. Rigid body refinement of the trimer led to an overall R/Rfree
of 28.6%/37.4%. The model was then ‘‘mutated’’ to the correct
sequence and rebuilt by Coot [48], then the protein structures
were refined with REFMAC [49] using TLS refinement [50]. The
final models were assessed using MolProbity [51]. The three
complex structures were refined and evaluated using the same
strategy. All statistics for data processing and refinement are
presented in Table 1. Electron density maps (2fo-fc) were
generated in Refmac [49] while simulated annealing omit maps
were generated by sa-omit-map, a part of the Crystallography and
NMR System (CNS) software [52].
Virus generation
Wild type and mutant viruses of NY107 (H7N2) and A/
Netherland/219/2003 (H7N7) were generated from plasmids by a
reverse genetics approach [53]. To generate viruses with amino
acid insertion or substitution in the HA, mutations were
introduced into plasmid DNA with an overlap extension PCR
approach [54]. Viruses derived by plasmid transfection of HK293
cells were propagated in eggs. The genomes of resulting virus
stocks were sequenced to detect the emergence of possible variants
during amplification.
Glycan binding analyses
Glycan microarray printing and recHA analyses have been
described previously [24,30,44,55] (see Table 2 for glycans used
for analyses in these experiments). Virus were analyzed on the
microarray as described previously [30].
PDB accession codes
The atomic coordinates and structure factors of NY107 are
available from the RCSB PDB under accession codes 3M5G for
the unliganded NY107, 3M5H for the NY107 with 39-SLN and
3M5I and 3M5J for NY107 with 69SLN and LSTb, respectively.
Accession/ID numbers for genes/proteins used in this
work
A/New York/107/03 (H7N2), Genbank: ACC55270; A/
Netherlands/219/03 (H7N7), Genbank: AAR02640; A/Hong
Kong/1-9/68 (H3N2), 2HMG; A/Duck/Ukraine/1/63 (H3N8),
PDB: 1MQL; A/South Carolina/1/18 (H1N1), PDB: 1RD8; A/
Puerto Rico/8/34 (H1N1), PDB: 1RU7; A/Swine/Iowa/15/30
(H1N1), PDB: 1RUY; A/Singapore/1/1957 (H2N2), PDB:
2WRC; A/Viet Nam/1203/04 (H5N1), PDB: 2FK0; A/Duck/
Singapore/3/97 (H5N3), PDB: 1JSM; A/Swine/Hong Kong/9/
98 (H9N2), PDB: 1JSD; A/Turkey/Italy/8000/02 (H7N3), PDB:
1TI8; C/Johannesburg/1/66, 1FLC.
Supporting Information
Figure S1 Sequence alignment of selected structurally available
HAs. Human H3 (PDB: 2HMG), Avian H3 (PDB: 1MQL), 1918-
Human H1 (PDB: 1RD8), 1934-Human H1 (PDB: 1RU7), Swine
H1 (PDB: 1RUY), 1957-Huamn H2 (PDB: 2WRC), Human H5
(PDB: 2FK0), Avian H5 (PDB: 1JSM), Swine H9 (PDB: 1JSD),
and Avian H7 (PDB: 1TI8) were used in the alignments. The
fusion domain of HA1 is highlighted in magenta, the vestigial
esterase domain is highlighted in green, the receptor binding
domain is highlighted in blue, and the fusion domain of HA2 is
highlighted in red. Residue numbering is based on the H3 HA
sequence.
Found at: doi:10.1371/journal.ppat.1001081.s001 (2.84 MB TIF)
Figure S2 Expression and purification of NY107. SDS-PAGE
reveals that NY107 was expressed as the HA0 form with a mass
approximately 60kDa (middle lane). Thrombin cleavage resulted in
an unexpected reduction in band size to a HA1/HA2 profile (right
lane) with possible multiple glycoforms for the HA2 clearly present.
Found at: doi:10.1371/journal.ppat.1001081.s002 (0.23 MB TIF)
Figure S3 Comparison of glycan binding to NY107 with other
HAs. A. Overlap of a2-3 ligands binding in the receptor binding
site from NY-H7 (green), Av-H3 (orange), 1930-Hu-H1 (magenta),
1957-Hu-H2 (cyan), Av-H5 (yellow), and Sw-H9 (grey). B.
Overlap of a2-6 linkage ligands binding in the receptor binding
site from NY-H7 (green), Av-H3 (orange), 1930-Hu-H1 (magenta),
1957-Hu-H2 (cyan), Av-H5 (yellow), and Sw-H9 (grey).
Found at: doi:10.1371/journal.ppat.1001081.s003 (2.55 MB TIF)
Figure S4 Simulated annealing omit maps of the receptor
binding site (contoured at 1s). A. NY107 (blue), B. NY107-39SLN
(orange), C. NY107-69SLN (red), and D. NY107-LSTb (magenta).
The protein model is shown in cartoon, and the residues involved
in the binding to receptor analogs were shown in sticks. Maps were
generated using version 1.2 of the Crystallography and NMR
System (CNS) software.
Found at: doi:10.1371/journal.ppat.1001081.s004 (1.93 MB
TIF)
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from NY107 (green), Av-H7 (marine) and HEF (magenta).
Found at: doi:10.1371/journal.ppat.1001081.s005 (1.12 MB TIF)
Table S1 Comparison of r.m.s.d. (A ˚) for different HA domains.
For analyzing differences in the overall structure, r.m.s.d. values
were calculated between monomers or domains of different HA’s,
after the Ca atoms of the HA2 domains were superposed by
sequence and structural alignment onto the equivalent domains of
NY107.
Found at: doi:10.1371/journal.ppat.1001081.s006 (0.04 MB
DOC)
Table S2 Comparison of r.m.s.d. (A ˚) for individual domains.
Each domain was superimposed separately to determine how the
individual NY107 domains compared to equivalent domains in the
other structures.
Found at: doi:10.1371/journal.ppat.1001081.s007 (0.04 MB
DOC)
Table S3 Molecular interactions between NY107 and receptor
analogs. The hydrogen bond cutoff is 3.8 A ˚ for the listing
interactions.
Found at: doi:10.1371/journal.ppat.1001081.s008 (0.07 MB
DOC)
Table S4 Glycan array differences between NY107, the fully
restored NY107-ins, and NL219 (virus and rHA). The color
coding in the left hand column reflects the same coloring scheme
used in Figures 2 and 3. Significant binding of samples to glycans
are qualitatively estimated based on relative strength of the signal
for the data shown in Figures 2 and 3 Strong (+++), weak (+).
Found at: doi:10.1371/journal.ppat.1001081.s009 (0.19 MB
DOC)
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